Fundz
Real-time · AI · Cross-signal

BD's Biosciences & Diagnostic Solutions just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on BD's Biosciences & Diagnostic Solutions, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
Watch the 2-minute tour · with sound

BD and Biosero Partner to Integrate Robotic Automation with Flow Cytometers for Drug Discovery and Development

Jan 23, 2025over 1 year ago

Contract Type

partnership

Description

BD and Biosero have announced a framework collaboration agreement to facilitate robotic arm integration with BD flow cytometry instruments, aiming to accelerate drug discovery and development. This partnership intends to develop new software capabilities within BD flow cytometer instrument software to be compatible with Biosero’s Green Button Go® software, as well as jointly support biopharmaceutical and contract research organizations with their custom research needs, enabling easy integration with robotic arms.

Company Information

Company

BD's Biosciences & Diagnostic Solutions

About

BD's Biosciences & Diagnostic Solutions is a division of Becton, Dickinson and Company. It focuses on developing tools and technologies for life sciences research. The division aims to provide innovative solutions for microbiology, immunology, and cellular analysis.

Predictive Intelligence
Strategic

ML-powered predictions for BD's Biosciences & Diagnostic Solutions's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.